DocCheck AG Net Assets
DocCheck AG net assets. Based on the latest financial reports, DocCheck AG (AJ91) has net assets worth €41.61 Million EUR (≈ $48.64 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€55.68 Million ≈ $65.09 Million USD) and total liabilities (€14.07 Million ≈ $16.45 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore AJ91 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €41.61 Million |
| % of Total Assets | 74.73% |
| Annual Growth Rate | 4.05% |
| 5-Year Change | 8.99% |
| 10-Year Change | 106.32% |
| Growth Volatility | 10.13 |
Net Assets of DocCheck AG (2005–2025)
Net assets of DocCheck AG from 2005 to 2025. This chart illustrates how DocCheck AG's net assets have evolved over time, based on quarterly financial data. See DocCheck AG (AJ91) net asset quality to measure how much of total assets are equity-financed.
Annual Net Assets for DocCheck AG (2005–2025)
The table below shows the annual net assets of DocCheck AG from 2005 to 2025. For live market cap and overall valuation, see DocCheck AG (AJ91) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €41.61 Million ≈ $48.64 Million |
+3.81% |
| 2024-12-31 | €40.08 Million ≈ $46.86 Million |
+5.38% |
| 2023-12-31 | €38.03 Million ≈ $44.47 Million |
-3.50% |
| 2022-12-31 | €39.41 Million ≈ $46.08 Million |
+3.24% |
| 2021-12-31 | €38.18 Million ≈ $44.63 Million |
+21.76% |
| 2020-12-31 | €31.35 Million ≈ $36.66 Million |
+42.17% |
| 2019-12-31 | €22.05 Million ≈ $25.78 Million |
+5.51% |
| 2018-12-31 | €20.90 Million ≈ $24.44 Million |
+1.32% |
| 2017-12-31 | €20.63 Million ≈ $24.12 Million |
+2.30% |
| 2016-12-31 | €20.17 Million ≈ $23.58 Million |
+2.59% |
| 2015-12-31 | €19.66 Million ≈ $22.98 Million |
+5.77% |
| 2014-12-31 | €18.59 Million ≈ $21.73 Million |
+3.33% |
| 2013-12-31 | €17.99 Million ≈ $21.03 Million |
+0.89% |
| 2012-12-31 | €17.83 Million ≈ $20.84 Million |
-0.93% |
| 2011-12-31 | €18.00 Million ≈ $21.04 Million |
-4.64% |
| 2010-12-31 | €18.87 Million ≈ $22.06 Million |
+1.64% |
| 2009-12-31 | €18.57 Million ≈ $21.71 Million |
+2.36% |
| 2008-12-31 | €18.14 Million ≈ $21.21 Million |
-2.68% |
| 2007-12-31 | €18.64 Million ≈ $21.79 Million |
-2.23% |
| 2006-12-31 | €19.06 Million ≈ $22.29 Million |
+1.28% |
| 2005-12-31 | €18.82 Million ≈ $22.01 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to DocCheck AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 841.0% over the analyzed period, indicating profitable operations and earnings retention.
DocCheck AG Net Assets Breakdown (December 2025)
DocCheck AG net assets breakdown by equity component as of December 2025.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €26.22 Million | 63.01% |
| Common Stock | €5.07 Million | 12.19% |
| Other Comprehensive Income | €-3.21 Million | -7.71% |
| Other Components | €13.52 Million | 32.51% |
| Total Equity | €41.61 Million | 100.00% |
DocCheck AG Competitors by Market Cap
The table below lists competitors of DocCheck AG ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
NexLiving Communities Inc
V:NXLV
|
$56.35 Million |
|
Helix BioPharma Corp.
TO:HBP
|
$56.36 Million |
|
3REN Berhad
KLSE:0328
|
$56.37 Million |
|
Mercor S.A.
WAR:MCR
|
$56.42 Million |
|
Fy Grp Ltd
TW:6807
|
$56.31 Million |
|
Chongqing Iron & Steel Company Limited
F:CGP
|
$56.31 Million |
|
Poznanska Korporacja Budowlana Pekabex SA
WAR:PBX
|
$56.30 Million |
|
Global View Co Ltd
TW:3040
|
$56.29 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in DocCheck AG's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 40,079,341 to 41,608,202, a change of 1,528,861 (3.8%).
- Net income of 5,334,223 contributed positively to equity growth.
- Dividend payments of 3,805,362 reduced retained earnings.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €5.33 Million | +12.82% |
| Dividends Paid | €3.81 Million | -9.15% |
| Total Change | €- | 3.81% |
Book Value vs Market Value Analysis
This analysis compares DocCheck AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.28x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 3.32x to 1.28x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2005-12-31 | €3.16 | €10.50 | x |
| 2006-12-31 | €3.23 | €10.50 | x |
| 2007-12-31 | €3.22 | €10.50 | x |
| 2008-12-31 | €3.29 | €10.50 | x |
| 2009-12-31 | €3.40 | €10.50 | x |
| 2010-12-31 | €3.50 | €10.50 | x |
| 2011-12-31 | €3.32 | €10.50 | x |
| 2012-12-31 | €3.49 | €10.50 | x |
| 2013-12-31 | €3.51 | €10.50 | x |
| 2014-12-31 | €3.65 | €10.50 | x |
| 2015-12-31 | €3.87 | €10.50 | x |
| 2016-12-31 | €4.00 | €10.50 | x |
| 2017-12-31 | €4.08 | €10.50 | x |
| 2018-12-31 | €4.15 | €10.50 | x |
| 2019-12-31 | €4.39 | €10.50 | x |
| 2020-12-31 | €6.12 | €10.50 | x |
| 2021-12-31 | €7.37 | €10.50 | x |
| 2022-12-31 | €7.62 | €10.50 | x |
| 2023-12-31 | €7.37 | €10.50 | x |
| 2024-12-31 | €7.90 | €10.50 | x |
| 2025-12-31 | €8.20 | €10.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently DocCheck AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 12.82%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 9.64%
- • Asset Turnover: 0.99x
- • Equity Multiplier: 1.34x
- Recent ROE (12.82%) is above the historical average (10.80%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2005 | 3.60% | 5.97% | 0.52x | 1.17x | €-1.19 Million |
| 2006 | 5.04% | 6.94% | 0.62x | 1.18x | €-930.47K |
| 2007 | 3.61% | 4.52% | 0.66x | 1.21x | €-1.17 Million |
| 2008 | 3.37% | 3.89% | 0.74x | 1.17x | €-1.18 Million |
| 2009 | 3.36% | 3.74% | 0.76x | 1.18x | €-1.21 Million |
| 2010 | 4.12% | 4.93% | 0.71x | 1.17x | €-1.09 Million |
| 2011 | 7.96% | 7.95% | 0.84x | 1.19x | €-357.81K |
| 2012 | 6.36% | 6.05% | 0.88x | 1.19x | €-633.29K |
| 2013 | 6.22% | 6.11% | 0.84x | 1.21x | €-662.10K |
| 2014 | 9.31% | 8.51% | 0.85x | 1.29x | €-125.45K |
| 2015 | 14.89% | 10.74% | 1.02x | 1.36x | €946.28K |
| 2016 | 13.30% | 10.27% | 1.01x | 1.29x | €661.57K |
| 2017 | 11.76% | 8.59% | 1.04x | 1.32x | €361.09K |
| 2018 | 10.92% | 8.03% | 1.02x | 1.34x | €191.91K |
| 2019 | 14.26% | 9.71% | 0.98x | 1.49x | €937.90K |
| 2020 | 29.77% | 14.58% | 1.34x | 1.52x | €6.11 Million |
| 2021 | 30.56% | 13.27% | 1.43x | 1.61x | €7.67 Million |
| 2022 | 16.31% | 10.33% | 0.96x | 1.64x | €2.43 Million |
| 2023 | 6.08% | 4.25% | 0.95x | 1.50x | €-1.46 Million |
| 2024 | 13.18% | 9.82% | 0.88x | 1.52x | €1.28 Million |
| 2025 | 12.82% | 9.64% | 0.99x | 1.34x | €1.17 Million |
Industry Comparison
This section compares DocCheck AG's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $475,971,563
- Average return on equity (ROE) among peers: -584.01%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| DocCheck AG (AJ91) | €41.61 Million | 3.60% | 0.34x | $56.32 Million |
| YIDU TECH INC. DL -00002 (0EL) | $4.01 Billion | -19.02% | 0.18x | $391.04 Million |
| RENALYTIX PLC LS-0025 (2O9) | $30.61 Million | -147.93% | 0.64x | $39.89 Million |
| CERTIVE SOLUTIONS INC. (5CE) | $-7.74 Million | 0.00% | 0.00x | $253.72K |
| UPHEALTH INC (5XV) | $106.14 Million | -210.11% | 2.20x | $5.44 Million |
| IQ-AI LTD. LS -01 (5Y1) | $302.53K | -108.12% | 2.07x | $123.35K |
| Victory Square Technologies Inc (6F6) | $38.70 Million | 51.45% | 0.10x | $33.41 Million |
| NIGHTINGALE HEALTH EO 1 (7XE) | $82.88 Million | -21.07% | 0.10x | $46.72 Million |
| TRELLUS HEALTH LS -0006 (85Q) | $25.09 Million | -35.11% | 0.03x | $215.06K |
| SPOTLITE360 IOT SOLUTIONS (87A0) | $295.66K | -4766.19% | 10.32x | $916.43K |
About DocCheck AG
DocCheck AG provides community, agency, and e-commerce services for the healthcare sector in Europe. It focuses on agency, access, and retail businesses. The company develops and implements communication concepts for healthcare and business-to-business sectors using both new and traditional media; sells medical supplies and medical technology through mail order to various medical professional gro… Read more